Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 4 | 0 | €693.90 | €766.92 | 10.522% |
| Neurocrine Bioscience | 27 | 0 | 4 | 0 | €130.30 | €140.34 | 7.705% |
| Gilead Sciences Inc | 12 | 1 | 3 | 0 | €60.91 | €86.77 | 42.458% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
| Icon plc | 18 | 0 | 3 | 0 | €280.90 | €318.99 | 13.562% |
| AbbVie Inc. | 21 | 0 | 3 | 0 | €150.40 | €174.43 | 15.980% |
| Biogen Inc. | 44 | 2 | 2 | 1 | €199.00 | €293.57 | 47.524% |
| AnaptysBio Inc | 8 | 1 | 2 | 0 | €24.80 | €46.24 | 86.452% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.68 | €4.63 | 25.769% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.14 | €10.05 | 143.085% |
| TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €15.64 | €28.06 | 79.441% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €49.74 | €78.42 | 57.665% |
| PTC Therapeutics Inc. | 14 | 5 | 2 | 0 | €31.00 | €41.51 | 33.911% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Corcept Therapeutics Inc. | 11 | 0 | 2 | 0 | €23.26 | €35.43 | 52.319% |
| Viking Therapeutics Inc | 6 | 0 | 2 | 0 | €68.40 | €100.00 | 46.199% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.00 | €124.93 | 4.108% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 1 | 0 | €874.20 | €957.22 | 9.497% |
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |